1-3 of 3
Malika Siker
Close
Sort by
Journal Articles

Real-World Experience with RTOG 0227 Induction for First Line Therapy of Primary CNS Lymphoma (PCNSL)

Ramsha Ahmed, Precious Anyanwu, Nirav N. Shah, Mehdi Hamadani, Walter Longo, Sumana Devata, Julie Pruett, Jennifer Connelly, Joseph Bovi, Malika Siker, Christopher Schultz, Timothy S. Fenske
Journal: Blood
Blood (2023) 142 (Supplement 1): 3122.
https://doi.org/10.1182/blood-2023-190961
Published: 2023
Journal Articles

Outcomes of Primary Bone Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Multicenter Retrospective Analysis

Alexandra Rezazadeh, Aniko Szabo, Kathleen Monahan, Arushi Khurana, David J. Inwards, Matthew A. Lunning, Amanda Cashen, Nancy L. Bartlett, Paolo F. Caimi, Thomas D. Rodgers, Paul M. Barr, Sayan Mullick Chowdhury, Narendranath Epperla, Hiruni Mendries, Brian T. Hill, Timothy Seijung Oh, Reem Karmali, Julie E. Chang, Gaurav Goyal, Benjamin M Parsons, Krista M. Isaac, Craig A. Portell, Malika Siker, David M King, Timothy S. Fenske
Journal: Blood
Blood (2021) 138 (Supplement 1): 1451.
https://doi.org/10.1182/blood-2021-145145
Published: 2021
Journal Articles

Local Control of Ocular Adnexal Lympho-Proliferative Disorders (OALD): Similar Outcomes in MALT and Non-MALT Histologies

Binod Dhakal, MD, Sridevi Ramalingam, MD, Jamie Shuff, MD, Narendranath Epperla, MD, Lisa Rein, MS, Anjishnu Banerjee, PhD, Malika Siker, MD, Paul R. Hosking, MD, Parameswaran Hari, MD MRCP, MS, Anita D'Souza, MBBS, MD, Ehab Atallah, MD, Beth Erisckson, MD, Timothy S. Fenske, MD, Mehdi Hamadani, MD
Journal: Blood
Blood (2015) 126 (23): 2711.
https://doi.org/10.1182/blood.V126.23.2711.2711
Published: 2015